Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Cutting edge: TLR ligands increase TCR triggering by slowing peptide-MHC class I decay rates.

Rudd BD, Brien JD, Davenport MP, Nikolich-Zugich J.

J Immunol. 2008 Oct 15;181(8):5199-203.

PMID:
18832671
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Enhancement of the priming efficacy of DNA vaccines encoding dendritic cell-targeted antigens by synergistic toll-like receptor ligands.

Grossmann C, Tenbusch M, Nchinda G, Temchura V, Nabi G, Stone GW, Kornbluth RS, Uberla K.

BMC Immunol. 2009 Aug 3;10:43. doi: 10.1186/1471-2172-10-43.

PMID:
19650904
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Evidence that the density of self peptide-MHC ligands regulates T-cell receptor signaling.

Anikeeva N, Gakamsky D, Schøller J, Sykulev Y.

PLoS One. 2012;7(8):e41466. doi: 10.1371/journal.pone.0041466. Epub 2012 Aug 3.

PMID:
22870225
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Presentation of type B peptide-MHC complexes from hen egg white lysozyme by TLR ligands and type I IFNs independent of H2-DM regulation.

Strong BS, Unanue ER.

J Immunol. 2011 Sep 1;187(5):2193-201. doi: 10.4049/jimmunol.1100152. Epub 2011 Jul 25.

PMID:
21788443
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type.

Yasutomo K, Lucas B, Germain RN.

J Immunol. 2000 Sep 15;165(6):3015-22.

PMID:
10975810
[PubMed - indexed for MEDLINE]
Free Article
6.
7.
8.

Dendritic cells recruit T cell exosomes via exosomal LFA-1 leading to inhibition of CD8+ CTL responses through downregulation of peptide/MHC class I and Fas ligand-mediated cytotoxicity.

Xie Y, Zhang H, Li W, Deng Y, Munegowda MA, Chibbar R, Qureshi M, Xiang J.

J Immunol. 2010 Nov 1;185(9):5268-78. doi: 10.4049/jimmunol.1000386. Epub 2010 Sep 29.

PMID:
20881190
[PubMed - indexed for MEDLINE]
Free Article
9.

Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells.

Khan S, Bijker MS, Weterings JJ, Tanke HJ, Adema GJ, van Hall T, Drijfhout JW, Melief CJ, Overkleeft HS, van der Marel GA, Filippov DV, van der Burg SH, Ossendorp F.

J Biol Chem. 2007 Jul 20;282(29):21145-59. Epub 2007 Apr 26.

PMID:
17462991
[PubMed - indexed for MEDLINE]
Free Article
10.

CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.

Stone JD, Stern LJ.

J Immunol. 2006 Feb 1;176(3):1498-505. Erratum in: J Immunol. 2006 Mar 15;176(6):3843.

PMID:
16424178
[PubMed - indexed for MEDLINE]
Free Article
11.

Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific.

Wu J, Meng Z, Jiang M, Zhang E, Trippler M, Broering R, Bucchi A, Krux F, Dittmer U, Yang D, Roggendorf M, Gerken G, Lu M, Schlaak JF.

Immunology. 2010 Mar;129(3):363-74. doi: 10.1111/j.1365-2567.2009.03179.x. Epub 2009 Nov 16.

PMID:
19922426
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

CD4+ T cells mature in the absence of MHC class I and class II expression in Ly-6A.2 transgenic mice.

Henderson SC, Berezovskaya A, English A, Palliser D, Rock KL, Bamezai A.

J Immunol. 1998 Jul 1;161(1):175-82.

PMID:
9647222
[PubMed - indexed for MEDLINE]
Free Article
13.

TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.

Crespo MI, Zacca ER, Núñez NG, Ranocchia RP, Maccioni M, Maletto BA, Pistoresi-Palencia MC, Morón G.

J Immunol. 2013 Feb 1;190(3):948-60. doi: 10.4049/jimmunol.1102725. Epub 2013 Jan 2.

PMID:
23284054
[PubMed - indexed for MEDLINE]
Free Article
14.

The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli.

Inaba K, Turley S, Iyoda T, Yamaide F, Shimoyama S, Reis e Sousa C, Germain RN, Mellman I, Steinman RM.

J Exp Med. 2000 Mar 20;191(6):927-36.

PMID:
10727455
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity.

Huppa JB, Axmann M, Mörtelmaier MA, Lillemeier BF, Newell EW, Brameshuber M, Klein LO, Schütz GJ, Davis MM.

Nature. 2010 Feb 18;463(7283):963-7. doi: 10.1038/nature08746.

PMID:
20164930
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

TLR-activated dendritic cells enhance the response of aged naive CD4 T cells via an IL-6-dependent mechanism.

Jones SC, Brahmakshatriya V, Huston G, Dibble J, Swain SL.

J Immunol. 2010 Dec 1;185(11):6783-94. doi: 10.4049/jimmunol.0901296. Epub 2010 Oct 27.

PMID:
20980632
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Comparison of antibodies and carbohydrates to target vaccines to human dendritic cells via DC-SIGN.

Cruz LJ, Tacken PJ, Pots JM, Torensma R, Buschow SI, Figdor CG.

Biomaterials. 2012 Jun;33(16):4229-39. doi: 10.1016/j.biomaterials.2012.02.036. Epub 2012 Mar 10.

PMID:
22410170
[PubMed - indexed for MEDLINE]
18.

Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells.

Nembrini C, Abel B, Kopf M, Marsland BJ.

J Immunol. 2006 Jun 15;176(12):7180-8.

PMID:
16751361
[PubMed - indexed for MEDLINE]
Free Article
20.

Dendritic cell function can be modulated through cooperative actions of TLR ligands and invariant NKT cells.

Hermans IF, Silk JD, Gileadi U, Masri SH, Shepherd D, Farrand KJ, Salio M, Cerundolo V.

J Immunol. 2007 Mar 1;178(5):2721-9.

PMID:
17312114
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk